Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...

NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA (BOTOX®) ...

Ipsen (GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, ...

Botox first became a household name for its ability to turn back the clock on facial aging. However, if you are considering Botox for cosmetic reasons and expecting Medicare coverage, you’ll be ...